Fair question.
Full text of article is available:
https://www.researchgate.net/figure/Models-of-payment-for-the-participation-of-research-subjects_tbl1_7737793
I searched my journal databases and there are just as many articles stating there are numerous disadvantages associated with payment of subjects. Payment is not common practice in Australia; more common in the US. Regardless, payment in Imagion's trial would require a fairly significant trial re-design...
Should we petition Red Cross to enable payment for plasma donations, and the sprog clinics to pay sperm donors also?
- Forums
- ASX - By Stock
- IBX
- Financial incentives for recruiting is not uncommon
Financial incentives for recruiting is not uncommon
-
-
-
Share
I think it's going to be really hard to get a 15 patient cohort without a trial redesign.
And then what about the next step, 300 people? You can understand the markets apprehension.
- There are more pages in this discussion • 13 more messages in this thread...
Featured News
Add IBX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.425M |
Open | High | Low | Value | Volume |
4.0¢ | 4.0¢ | 3.6¢ | $27.63K | 750.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 63865 | 3.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 25000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 63865 | 0.037 |
1 | 28571 | 0.035 |
1 | 20000 | 0.034 |
2 | 48750 | 0.033 |
1 | 92000 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 90637 | 1 |
0.047 | 14800 | 1 |
0.048 | 13016 | 2 |
0.050 | 105885 | 2 |
0.055 | 88714 | 1 |
Last trade - 13.05pm 04/10/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |